学校に通う年齢の白血病患者の自己ケアスキルの訓練:現在の証拠と将来の方向性
Ting Feng1, Chaolang Zhang1, Li Ying Zhang2
1Hematology/Oncology, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Zhejiang, 310000, China.
European journal of pediatrics
|February 12, 2026
まとめ
セルフケアのスキルを教えることは,白血病の子どもたちが自分の状態を管理し,生活の質を改善するために不可欠です. 将来の取り組みは,小児がんケアにおけるよりよい長期的な成果のために,統一された,多学科的なアプローチに焦点を当てるべきである.
科学分野:
- 小児腫瘍学 小児腫瘍学
- がん治療のサポートケアについてです.
- 健康心理学 心理学について
背景:
- 白血病の学校に通う年齢の子どもは,治療中に身体的,心理的,社会的課題に直面します.
- セルフケア介入は,これらの患者の治療順守と生活の質を改善するために不可欠です.
- 現在の自己ケアプログラムは,医療および心理社会的ニーズに対応しているが,標準化されたモデルや長期的評価が欠けている.
研究 の 目的:
- 過去10年間にわたって,白血病の学校に通う年齢の子どもに対する自己ケアスキルの訓練に関する文献をレビューする.
- 医療,心理,教育,技術強化のアプローチを含む,現在の自己ケアプログラムのターゲットを特定する.
- 既存のギャップを強調し,統合された多学科的な自己ケア戦略の将来の方向性を提案する.
主な方法:
- 過去10年間に発表された研究の体系的な文献レビュー.
- 医療,心理,教育,技術支援介入に焦点を当てた自己ケアプログラムの分析.
- 現在の自己ケアのアプローチにおける共通の課題と限界を特定する.
主要な成果:
- 現在の自己ケアプログラムは,治療の遵守,心理社会的回復力,および全体的な機能の向上において有望であることが示されています.
- 介入には,医療管理,心理的支援,教育要素,技術統合などがあります.
- 明らかにされた重要なギャップは,統一モデル,縦断的なフォローアップ,文化的に敏感な方法の欠如です.
結論:
- 自己ケアスキルのトレーニングは,小児白血病のサポートケアに不可欠です.
- 将来の研究は,統一された,多学科的で,家族を中心とした自己ケアモデルの開発を優先すべきです.
- 自己ケア教育を日常的な臨床実践と政策に統合することで,生存者の長期的な回復力と生活の質を向上させることができます.
さらに関連する動画
関連する概念動画
The Evidence for Evolution
48.4K
Genetic variations accumulating within populations over generations give rise to biological evolution. Evolutionary changes can result in the formation of novel varieties and entire new species. These changes are responsible for the diverse forms of life inhabiting the planet. The evidence for evolution suggests that all living organisms descended from common ancestors.
48.4K
Patient-centered Care
3.1K
Patient-centered care involves delivering care beyond inpatient hospitalization. Reflective practice can enhance a patient-centered approach. Reflective practice is a process of reasoning that considers all aspects of the present situation, including practicalities, learning from personal practice, and consideration of patient needs. Patients appreciate care decisions made while considering their input. Involving the patient in their care provides the patient with a sense of contribution rather...
3.1K
Pharmacodynamics in Geriatric Patients: Effects of Age
241
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
241
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
713
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
713
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
265
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
265
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
227
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
227


